BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 14697227)

  • 1. Binding of prion proteins to lipid membranes.
    Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
    Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.
    Kazlauskaite J; Sanghera N; Sylvester I; Vénien-Bryan C; Pinheiro TJ
    Biochemistry; 2003 Mar; 42(11):3295-304. PubMed ID: 12641461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of prion protein to lipid membranes and implications for prion conversion.
    Sanghera N; Pinheiro TJ
    J Mol Biol; 2002 Feb; 315(5):1241-56. PubMed ID: 11827491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the cellular prion protein with raft-like lipid membranes.
    Elfrink K; Nagel-Steger L; Riesner D
    Biol Chem; 2007 Jan; 388(1):79-89. PubMed ID: 17214553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into early events in the aggregation of the prion protein on lipid membranes.
    Sanghera N; Swann MJ; Ronan G; Pinheiro TJ
    Biochim Biophys Acta; 2009 Oct; 1788(10):2245-51. PubMed ID: 19703409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lipid rafts and GM1 in the segregation and processing of prion protein.
    Botto L; Cunati D; Coco S; Sesana S; Bulbarelli A; Biasini E; Colombo L; Negro A; Chiesa R; Masserini M; Palestini P
    PLoS One; 2014; 9(5):e98344. PubMed ID: 24859148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
    J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
    Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
    J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform.
    Baron GS; Caughey B
    J Biol Chem; 2003 Apr; 278(17):14883-92. PubMed ID: 12594216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
    Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
    Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation and fibrillization of prions in lipid membranes.
    Kazlauskaite J; Pinheiro TJ
    Biochem Soc Symp; 2005; (72):211-22. PubMed ID: 15649144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
    Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
    Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper binding to the PrP isoforms: a putative marker of their conformation and function.
    Shaked Y; Rosenmann H; Hijazi N; Halimi M; Gabizon R
    J Virol; 2001 Sep; 75(17):7872-4. PubMed ID: 11483731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
    Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
    Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
    Kaneko K; Peretz D; Pan KM; Blochberger TC; Wille H; Gabizon R; Griffith OH; Cohen FE; Baldwin MA; Prusiner SB
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11160-4. PubMed ID: 7479957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative binding of dominant-negative prion protein to kringle domains.
    Ryou C; Prusiner SB; Legname G
    J Mol Biol; 2003 May; 329(2):323-33. PubMed ID: 12758079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.